Filing Flows › Bruker (BRKR) › Capital expenditures
Bruker (BRKR) capital expenditures by quarter
Bruker's capital expenditures were $21.5M in Q3 2026 (third quarter 2026), -11% from Q1 2026. Over the last 4 quarters it ranged from $21.5M (Q3 2026) to $26.0M (Q1 2025).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $21.5M | -11% | — |
| Q1 2026 | $24.2M | +7% | -7% |
| Q4 2025 | $22.6M | -13% | — |
| Q1 2025 | $26.0M | — | — |
Q3 2026 at a glance
Bruker, Q3 2026: revenue $874M (+2% year over year), operating margin -10.4%, net loss $110M, operating cash flow $118M. The chart follows the revenue to costs, profit and cash.
Questions
What is Bruker's capital expenditures?
Bruker's capital expenditures were $21.5M in Q3 2026 (third quarter 2026), -11% from Q1 2026.
How has Bruker's capital expenditures changed?
Over the last 4 quarters it ranged from $21.5M (Q3 2026) to $26.0M (Q1 2025).